Rybelsus vs. Contrave
See how Rybelsus and Contrave compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Rybelsus is an oral GLP-1 receptor agonist approved for type 2 diabetes and cardiovascular risk reduction, while Contrave is an oral combination pill approved specifically for chronic weight management.
Rybelsus is FDA-approved for diabetes, not weight loss, so its weight-loss use is off-label, whereas Contrave's only FDA-approved use is weight management.
Both cause similar early GI side effects, but Contrave carries a boxed warning for suicidal thoughts from its bupropion component and Rybelsus carries a boxed warning for thyroid tumors seen in animal studies.
Rybelsus vs. Contrave Drug Summary
Rybelsus
Rybelsus (semaglutide) is an oral GLP-1 receptor agonist FDA-approved to control blood sugar in adults with type 2 diabetes and to reduce cardiovascular risk in those with existing heart disease. It is taken as a tablet once daily on an empty stomach, with the dose increased gradually over about two months. It is sometimes used off-label for weight loss in people without diabetes.
Contrave
Contrave combines naltrexone and bupropion, two older drugs repurposed into one extended-release combination pill. It is FDA-approved for chronic weight management in adults with obesity, or overweight plus a weight-related condition, alongside diet and exercise changes. The dose is stepped up over three weeks to a twice-daily maintenance dose.
Rybelsus vs. Contrave Side Effects
Rybelsus
Contrave
Rybelsus vs. Contrave Dosage
Rybelsus
Contrave
| STAGE | DOSE | WHEN |
| Starting dose | 3 mg once daily | Days 1-30 |
| Maximum dose | 14 mg once daily | Day 61 onward |
| Dose changes | 2 increases | Every 30 days |
| STAGE | DOSE | WHEN |
| Starting dose | 8 mg/90 mg once daily | Week 1 |
| Maximum dose | 16 mg/180 mg twice daily | Week 3 |
| Dose changes | 2 increases | Every week |
Rybelsus
| STAGE | DOSE | WHEN |
| Starting dose | 3 mg once daily | Days 1-30 |
| Maximum dose | 14 mg once daily | Day 61 onward |
| Dose changes | 2 increases | Every 30 days |
Contrave
| STAGE | DOSE | WHEN |
| Starting dose | 8 mg/90 mg once daily | Week 1 |
| Maximum dose | 16 mg/180 mg twice daily | Week 3 |
| Dose changes | 2 increases | Every week |
Rybelsus vs. Contrave Indications
Rybelsus
Rybelsus is approved to improve blood sugar control in adults with type 2 diabetes and, as of an October 2025 label update, to reduce the risk of major cardiovascular events in those with type 2 diabetes and existing heart disease. It is not approved for type 1 diabetes or for weight loss, though doctors sometimes prescribe it off-label for weight management.
Type 2 diabetes blood sugar control
Cardiovascular risk reduction with heart disease
Off-label: weight loss in people without diabetes
Contrave
Contrave is approved only for chronic weight management in adults with obesity or overweight who also have a weight-related condition such as high blood pressure or type 2 diabetes. It is meant to be used with a reduced-calorie diet and increased physical activity, and it is not approved to treat depression or aid smoking cessation despite containing bupropion.
Chronic weight management in adults with obesity
Weight management with a related condition
Used alongside diet and exercise changes
Rybelsus vs. Contrave Pros and Cons
Rybelsus
Rybelsus is the only oral GLP-1 available, appealing to patients who want to avoid injections, and its cardiovascular benefit is now part of its official label. It requires strict dosing rules and carries a boxed warning that limits its use in people with certain thyroid or endocrine histories.
Pros
Oral tablet, no injections required
FDA-approved cardiovascular risk reduction on top of blood sugar control
Once-daily dosing with no titration beyond two months
Cons
Must be taken on an empty stomach, no food for 30 minutes
Boxed warning for thyroid C-cell tumor risk seen in animal studies
Not FDA-approved for weight loss, so coverage for that use is limited
Contrave
Contrave is the only oral non-GLP-1 weight-loss combination pill on the market, giving patients an alternative for those who cannot or prefer not to use a GLP-1 drug. It carries a boxed warning for suicidal thoughts from its bupropion component and has more contraindications, including seizure disorders and uncontrolled hypertension.
Pros
No special fasting or timing rules around food
Only oral non-GLP-1 combination pill approved for weight management
Alternative for patients who cannot or prefer not to take a GLP-1
Cons
Boxed warning for suicidal thoughts and behaviors
More contraindications, including seizure disorder and hypertension
Twice-daily dosing at maintenance, versus once daily for Rybelsus
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.